124
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Clinical significance of serum hepcidin in the diagnosis and treatment of patients with anemia of chronic disease: a meta-analysis

&
Pages 296-301 | Received 14 Jul 2020, Accepted 28 Jan 2021, Published online: 02 Mar 2021

References

  • Bansal, S.S., et al., 2009. Quantification of hepcidin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid communications in mass spectrometry, 23 (11), 1531–1542.
  • Basseri, R.J., et al., 2013. Hepcidin is a key mediator of anemia of inflammation in Crohn’s disease. Journal of crohn’s and colitis, 7 (8), e286–e291.
  • Boshuizen, M., et al., 2020. Potential of parameters of iron metabolism for the diagnosis of anemia of inflammation in the critically ill. Transfusion medicine and hemotherapy: offizielles organ der deutschen gesellschaft fur transfusionsmedizin und immunhamatologie, 47 (1), 61–67.
  • Busbridge, M., et al., 2009. Development of a novel immunoassay for the iron regulatory peptide hepcidin. British journal of biomedical science, 66 (3), 150–157.
  • Cheng, P.P., et al., 2011. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clinical and experimental medicine, 11 (1), 33–42.
  • DeLoughery, T.G., 2017. Iron deficiency anemia. Medical Clinics of North America, 101 (2), 319–332.
  • Deschemin, J.C., et al., 2017. Pulmonary iron homeostasis in hepcidin knockout mice. Frontiers in physiology, 8, 804.
  • Gangat, N., and Wolanskyj, A.P., 2013. Anemia of chronic disease. Seminars in hematology, 50 (3), 232–238.
  • Ganz, T., 2003. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood, 102 (3), 783–788.
  • Ganz, T., and Nemeth, E., 2011. Hepcidin and disorders of iron metabolism. Annual review of medicine, 62, 347–360.
  • Girelli, D., Nemeth, E., and Swinkels, D.W., 2016. Hepcidin in the diagnosis of iron disorders. Blood, 127 (23), 2809–2813.
  • Hadziahmetovic, M., et al., 2011. Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. Investigative ophthalmology & visual science, 52 (1), 109–118.
  • Hentze, M.W., et al., 2010. Two to tango: regulation of Mammalian iron metabolism. Cell, 142 (1), 24–38.
  • Joosten, E., and Lioen, P., 2015. Iron deficiency anemia and anemia of chronic disease in geriatric hospitalized patients: How frequent are comorbidities as an additional explanation for the anemia? Geriatrics & gerontology international, 15 (8), 931–935.
  • Kali, A., Charles, M.V., and Seetharam, R.S., 2015. Hepcidin – a novel biomarker with changing trends. Pharmacognosy reviews, 9 (17), 35–40.
  • Kim, A., et al., 2014. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood, 123 (8), 1129–1136.
  • Krause, A., et al., 2000. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS letters, 480 (2–3), 147–150.
  • Kroot, J.J., et al., 2009. (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Analytical biochemistry, 389 (2), 124–129.
  • Li, J., and Fine, J.P., 2011. Assessing the dependence of sensitivity and specificity on prevalence in meta-analysis. Biostatistics, 12 (4), 710–722.
  • Li, J., Fine, J.P., and Safdar, N., 2007. Prevalence-dependent diagnostic accuracy measures. Statistics in medicine, 26 (17), 3258–3273.
  • Li, Y., et al., 2018. Diagnostic value and clinical significance of serum hepcidin level in iron deficiency anemia. International journal of laboratory hematology, 39 (3), 56–58.
  • Lunova, M., et al., 2017. Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells. The journal of pathology, 241 (1), 104–114.
  • Macdougall, I.C., et al., 2010. Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clinical journal of the American society of nephrology: CJASN, 5 (9), 1681–1689.
  • Mahajan, G., et al., 2017. Hepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia. Blood research, 52 (3), 212–217.
  • Murawska, N., Fabisiak, A., and Fichna, J., 2016. Anemia of chronic disease and iron deficiency anemia in inflammatory bowel diseases: pathophysiology, diagnosis, and treatment. Inflammatory bowel diseases, 22 (5), 1198–1208.
  • Okuturlar, Y., et al., 2016. Comparison of serum paraoxonase and arylesterase activities between iron deficiency anemia patients and chronic kidney disease patients with anemia. Renal failure, 38 (5), 781–786.
  • Pagani, A., et al., 2019. Hepcidin and Anemia: a tight relationship. Frontiers in physiology, 10, 1294.
  • Park, C.H., et al., 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. The journal of biological chemistry, 276 (11), 7806–7810.
  • Przybyszewska, J., et al., 2013. Serum prohepcidin and other iron metabolism parameters in elderly patients with anemia of chronic disease and with iron deficiency anemia. Polish archives of internal medicine, 123 (3), 105–111.
  • Shu, T., et al., 2015. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis. European journal of haematology, 94 (1), 67–73.
  • Theurl, I., et al., 2011. Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo. Haematologica, 96 (12), 1761–1769.
  • Wang, H., et al., 2017. Correlation between serum Hepcidin and sTfR in children with iron deficiency anemia and the value of the combined diagnosis. Chinese journal of health laboratory technology, 27 (3), 2778–2780.
  • Wang, W.J., et al., 2015. Diagnostic value of hepcidin in elderly patients with iron deficiency anemia and anemia of chronic disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 23, 155–158.
  • Zhou, B., 2015. Significance of serum hepcidin in differential diagnosis of iron deficiency anemia and Anemia of Chronic Disease. Chinese journal of control of endemic diseases, 30 (3), 77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.